SG3 Management’s Clorox CLX Stock Holding History

SG3 Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$417K	–	485
2022 Q1	$417K	Buy	+3,000	New	+$460K	0.01%	646

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG3 Management's CLX Position: Q2 2022 in Review

SG3 Management sold out of Clorox (CLX) in Q2 2022, closing a stake of 3,000 shares — an estimated $417K sold.

SG3 Management first reported a position in CLX in Q1 2022 and held it in 1 quarter. The position peaked at $417K in Q1 2022. 1,081 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

SG3 Management reported no remaining Clorox position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 3,000 Clorox shares in Q2 2022, an estimated $417K.
SG3 Management first reported a position in Clorox in Q1 2022 and held it in 1 quarter.
SG3 Management's Clorox position peaked at $417K in Q1 2022.
1,081 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.